SN

Sunil Navalgund

Active Director Director DIN 10097367
DIN 10097367 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Sunil Navalgund

Data last updated:

Sunil Navalgund is a Director at Diligent Super Speciality Clinic Private Limited (since 2023). Diligent Super Speciality Clinic Private Limited reported revenue of ₹61.4 Lakh (FY 2024).

DIN 10097367
Primary Designation Director
First Appointment 31 Mar 2023
Oldest Company Age 3 yrs
Largest company Diligent Super Speciality Clinic Private Limited · ₹61.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20232023₹61.4 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Diligent Super Speciality Clinic Private Limited
Premium access

Shareholding and investment profile for Sunil Navalgund

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Navalgund

Sunil Navalgund currently holds 1 directorship: Diligent Super Speciality Clinic Private Limited (Director, since 31 Mar 2023, revenue ₹61.4 Lakh (FY 2024)).

Sunil Navalgund was first appointed on 31 Mar 2023 as Director at Diligent Super Speciality Clinic Private Limited.

The current boards of Sunil Navalgund's companies include Hemarlahalli Munichannappa Sunitha (Diligent Super Speciality Clinic Private Limited), Karnam Vaddatti Sundeep (Diligent Super Speciality Clinic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available